Perrigo Co. Plc (PRGO)
10.25
+0.09
(+0.89%)
USD |
NYSE |
Jun 18, 16:00
10.41
+0.16
(+1.56%)
After-Hours: 20:00
Perrigo Accounts Receivable (Quarterly) : 732.80M for March 31, 2026
Accounts Receivable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Accounts Receivable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 732.80M |
| December 31, 2025 | 650.10M |
| September 30, 2025 | 675.60M |
| June 30, 2025 | 706.60M |
| March 31, 2025 | 755.00M |
| December 31, 2024 | 686.20M |
| September 30, 2024 | 813.30M |
| June 30, 2024 | 751.60M |
| March 31, 2024 | 805.70M |
| December 31, 2023 | 768.10M |
| September 30, 2023 | 761.40M |
| June 30, 2023 | 779.90M |
| March 31, 2023 | 770.40M |
| December 31, 2022 | 738.60M |
| September 30, 2022 | 739.50M |
| June 30, 2022 | 777.10M |
| March 31, 2022 | 711.80M |
| December 31, 2021 | 693.10M |
| September 30, 2021 | 728.40M |
| June 30, 2021 | 642.60M |
| March 31, 2021 | 659.40M |
| December 31, 2020 | 613.20M |
| September 30, 2020 | 1.119B |
| June 30, 2020 | 1.024B |
| March 31, 2020 | 1.325B |
| Date | Value |
|---|---|
| December 31, 2019 | 1.270B |
| September 30, 2019 | 1.128B |
| June 30, 2019 | 1.134B |
| March 31, 2019 | 1.119B |
| December 31, 2018 | 1.073B |
| September 30, 2018 | 1.080B |
| June 30, 2018 | 1.130B |
| March 31, 2018 | 1.123B |
| December 31, 2017 | 1.131B |
| September 30, 2017 | 1.077B |
| June 30, 2017 | 1.066B |
| March 31, 2017 | 1.050B |
| December 31, 2016 | 1.176B |
| September 30, 2016 | 1.124B |
| June 30, 2016 | 1.194B |
| March 31, 2016 | 1.188B |
| December 31, 2015 | 1.193B |
| September 30, 2015 | 1.232B |
| June 30, 2015 | 1.282B |
| March 31, 2015 | 881.70M |
| June 30, 2014 | 935.10M |
| March 31, 2014 | 793.10M |
| December 31, 2013 | 769.80M |
| September 30, 2013 | 702.60M |
| June 30, 2013 | 651.90M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Receivable (Quarterly) Benchmarks
| Avadel Pharmaceuticals Plc | 42.44M |
| Jazz Pharmaceuticals Plc | 836.30M |
| Iterum Therapeutics Plc | 0.448M |
| GH Research Plc | -- |
| Viatris, Inc. | 2.577B |